Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in FTRE — Fortrea Holdings Inc.

CIK 1692234 Seattle, WA
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$4,231,781
+$3,281,062 QoQ
Shares Held
243,206
+141.0% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 55% Shared 0% None 45%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. FTRE ranks #60 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in FTRE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,231,781 243,206
2026-03-31 $950,719 100,926
2025-12-31 $964,806 55,931
2025-09-30 $1,280,149 152,037
2025-06-30 $655,018 132,595
2025-03-31 $21,682 2,872
2024-12-31 $4,091,153 219,365
2024-09-30 $3,632,420 181,621
2024-06-30 $6,558,840 281,013
2024-03-31 $3,308,659 82,428
2023-12-31 $508,247 14,563
2023-09-30 $872,936 30,533